Figure S1 from A Phase 1b Dose Escalation Trial of NC-6300 (Nanoparticle Epirubicin) in Patients with Advanced Solid Tumors or Advanced, Metastatic, or Unresectable Soft-tissue Sarcoma

Autor: Richard F. Riedel, Iulian Bobe, Atsushi Osada, Juneko E. Grilley Olson, Arun S. Singh, Fadi Braiteh, Warren Chow, Sanjay Goel, Sant P. Chawla
Rok vydání: 2023
DOI: 10.1158/1078-0432.22476191.v1
Popis: Figure S1. shows total epirubicin concentrations (mean {plus minus} SD) at the end of infusion of 170 mg/m2 NC-6300 across cycles.
Databáze: OpenAIRE